Tag Archives: pharmaceutical industry

We are not talking about the rainbows

A while ago, Research Enterprise argued that the “manufactured substantially” requirement in Bayh-Dole, for all its gesture toward American manufacturing, is a nearly empty requirement. Absurdly narrow, easy to circumvent, waivable by federal agencies (“we tried and failed” or “we … Continue reading

Posted in Bayh-Dole | Tagged , , , | Leave a comment

The IPA and Wisconsin’s 1969 Patent Policy, 13

Things start here: The IPA and Wisconsin’s 1969 Patent Policy, 1 The Harbridge House report According to the Harbridge House report on federal patent policy, from the 1930s until the 1950s, the pharmaceutical industry was the primary source of funding … Continue reading

Posted in Bayh-Dole, History, Policy, Sponsored Research | Tagged , , , , | Comments Off on The IPA and Wisconsin’s 1969 Patent Policy, 13